The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.93BCNY
1.49B · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
1.48BCNY
221.67M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-7.26%
Updated Oct 21, 2026
Beta
0.6160x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-24.26%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
9.93BCNY
1.49B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
9.25BCNY
1.39B · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
256.32x
Updated Oct 21, 2026
Price to Sales (TTM)
6.19x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6.71×.Updated Oct 21, 2026
Price to Book (MRQ)
9.49x
Updated Oct 21, 2026
Enterprise to Revenue
6.25x
Updated Oct 21, 2026
Enterprise to EBITDA
-70.61x
Updated Oct 21, 2026
Gross Margin
85.50%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 87.95%.Updated Oct 21, 2026
Profit Margin
-7.26%
Updated Oct 21, 2026
Operating Margin
-7.99%
Updated Oct 21, 2026
Return on Assets (TTM)
-6.17%
Updated Oct 21, 2026
Return on Equity (TTM)
-10.40%
Updated Oct 21, 2026
Revenue (TTM)
1.48BCNY
221.67M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
7.70CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-11.30%
Updated Oct 21, 2026
Gross Profit (TTM)
1.30BCNY
194.95M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
-130.97MCNY
-19.63M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-107.41MCNY
-16.10M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-11.31%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
505.56KCNY
75.78K · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-102.07MCNY
-15.30M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.38%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
122.84%
Updated Oct 21, 2026
Minority Interest (Equity)
18.08MCNYFY2025 · Dec 31, 2025
Revenue
1.53BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
141.44MCNYFY2025 · Dec 31, 2025
Gross Profit
1.39BCNYFY2025 · Dec 31, 2025
Operating Income
-116.88MCNY
-17.52M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-89.99MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.75MCNYFY2025 · Dec 31, 2025
Net Income
-92.74MCNYFY2025 · Dec 31, 2025
EBIT
-88.43MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-35.76MCNYFY2025 · Dec 31, 2025
Research & Development
431.93MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
771.16MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.84MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.90MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.56MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4700CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4700CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
194.11MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
194.11MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-92.74MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.51MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-79.66MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-207.41MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
553.52MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-92.74MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
15.14MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-236.63KCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-1.83MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-127.75MCNYFY2025 · Dec 31, 2025
Sale of Investments
113.34MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-40.66MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-55.07MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
261.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-31.76MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.81MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-58.81MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
168.11MCNYFY2025 · Dec 31, 2025
Shares Outstanding
193.34MSharesUpdated Oct 21, 2026
Float Shares
135.56MSharesUpdated Oct 21, 2026
% Held by Insiders
29.62%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
3.52%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
395.94MCNY
59.35M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
2.05CNYUpdated Oct 21, 2026
Total Debt (MRQ)
281.23MCNY
42.15M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.2893x
Updated Oct 21, 2026
Current Ratio (MRQ)
1.29x
Updated Oct 21, 2026
Book Value per Share (MRQ)
4.99CNYUpdated Oct 21, 2026
Total Assets
1.68BCNY
252.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
750.44MCNYFY2025 · Dec 31, 2025
Total Liabilities
642.64MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
933.83MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
165.85MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
476.79MCNYFY2025 · Dec 31, 2025
Cash
552.78MCNYFY2025 · Dec 31, 2025
Cash Equivalents
45.63MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
598.41MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
21.29MCNYFY2025 · Dec 31, 2025
Accounts Receivable
68.29MCNYFY2025 · Dec 31, 2025
Accounts Payable
28.90MCNYFY2025 · Dec 31, 2025
Short-term Debt
129.42MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
834.76KCNYFY2025 · Dec 31, 2025
Long-term Debt
151.67MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.48MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
193.34MCNYFY2025 · Dec 31, 2025
Retained Earnings
179.04MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.04BCNY
156.13M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
25.60MCNYFY2025 · Dec 31, 2025
52-Week Low
43.80CNYUpdated Oct 21, 2026
52-Week High
122.80CNYUpdated Oct 21, 2026
52-Week Change
-24.26%
vs all stocks
Updated Oct 21, 2026
Beta
0.6160x
vs all stocks
Updated Oct 21, 2026
50-Day MA
51.17CNYUpdated Oct 21, 2026
200-Day MA
65.00CNYUpdated Oct 21, 2026
Avg 10-Day Volume
10.89MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
11.51MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.5600CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.85Profit Margin: -0.07
Financial Health
Altman Z-Score 10.35: safe zoneNotable
Altman Z-Score: 10.35
High earnings qualityNotable
Earnings Quality Score: 0.71
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $1.49B, above the global median of $1.14BNotable
Market cap (USD): 1,488,370,767.104Global Median: 1,137,180,293.291
Companies that share the same coordination system — how they create, deliver, or capture value.